U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07444424) titled 'A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants' on Feb. 26.
Brief Summary: The purpose of the study is to assess the effect of AZD5004 on the pharmacokinetics (PK) of mitiglinide and pioglitazone in healthy participants.
Study Start Date: March 13
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: AZD5004
AZD5004 will be administered orally.
DRUG: Mitiglinide
Mitiglinide will be administered orally.
DRUG: Pioglitazone
Pioglitazone will be administered orally.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Published by HT Digi...